TwinKnowledge | $3,700,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
Certified by Founder
Lodge
LoQus23 Therapeutics Ltd
start up
United Kingdom
- Cambridge, Cambridgeshire
- 02/10/2024
- Series A
- $46,550,175
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
- Industry Biotechnology Research
- Website https://loqus23.com/
- LinkedIn https://www.linkedin.com/company/loqus23-therapeutics-ltd/
SchoolAI | $25,000,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Cambrian Network | $5,900,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)